Reinforcement of resin-modified glass-ionomer cement with glass fiber and graphene oxide.

OBJECTIVE: To evaluate the effect of adding glass fiber and graphene oxide to a resin-modified glass ionomer cement (RMGIC). METHODS: Experimental RMGICs were prepared by adding separately and simultaneously glass fibers (5, 10, and 20 wt%) and graphene oxide (1, 3, and 5 wt%) to the powder of RMGIC with different ratios. The samples were examined under SEM and XRD. The surface roughness, flexural strength, Vickers microhardness, water sorption, and solubility were investigated. Data were analyzed using ANOVA and Tukey tests (p = 0.05). RESULTS: Adding fiber and graphene oxide to RMCIS increased the surface roughness, flexural strength, and microhardness. The highest surface roughness value was obtained in the 20% fiber+5% graphene oxide adding group and the lowest in the control group (p < 0.05). The highest microhardness and flexural strength values were acquired in the 20% fiber-adding group and the lowest in the control group (p < 0.05). 10% and 20% fiber addition increased water sorption and solubility (p < 0.05). Adding 3%, 5% graphene oxide, and 20% fiber+5% graphene oxide reduced water sorption (p < 0.05). The highest water sorption was found in the 20% fiber-adding group and the lowest in the 5% graphene oxide and %20 fiber+5% graphene oxide-adding groups (p < 0.05). Graphene oxide alone and together with fiber did not affect the solubility (p > 0.05). CONCLUSION: The results show that reinforcement of RMGIC with glass fiber and graphene oxide may improve the mechanical properties. But the glass fibers may cause more water sorption and solubility. Graphene oxide may decrease water sorption of RMGIC and fiber-reinforced RMGIC.

The clinical success of repaired posterior composite restorations with and without silane application.

OBJECTIVE: To evaluate the clinical success of posterior composite restorations repaired with and without silane application for up to 2 years. MATERIALS AND METHOD: In this retrospective study, patient record files acquired from the 40 patients who were treated due to needing repair for two class II defective composite restorations and visited the clinical practice for regular check-up visits were used. In the experimental group, the defective restorations were repaired using a silane coupling agent (Porcelain Primer), a universal adhesive (G-Premio Bond), and a microhybrid resin composite (Charisma Smart). In the control group, the restorations were repaired using the universal adhesive and the resin composite without silane coupling agent application. The repaired restorations were blindly assessed by two calibrated examiners using modified USPHS criteria at baseline, 6 months, 1, and 2 years. The data were analyzed using non-parametric tests (p = 0.05). RESULTS: After 2 years, 80 repaired class II restorations were evaluated. No restoration of either the control or silane-treated group failed. After 2 years, there were no statistically significant differences between the experimental and control groups (p > 0.05). The differences in surface roughness were observed in each group over time (p < 0.05). There were no variations in other criteria over time (p > 0.05). CONCLUSION: There was no significant effect of the silane coupling agent on restoration repair survival. CLINICAL RELEVANCE: The repair of localized defects of the posterior composite restorations either with or without silane application is a conservative treatment option that may increase the clinical success of these restorations.

A 3-year retrospective study of clinical durability of bulk-filled resin composite restorations.

Objectives: This study aimed to assess the clinical longevity of a bulk-fill resin composite in Class II restorations for 3-year. Materials and Methods: Patient record files acquired from the 40 patients who were treated due to needed 2 similar sizes Class II composite restorations were used for this retrospective study. In the experimental cavity, the flowable resin composite SDR was inserted in the dentinal part as a 4 mm intermediate layer. A 2 mm coverage layer with a nano-hybrid resin composite (CeramX) was placed on SDR. The control restoration was performed by an incremental technique of 2 mm using the nano-hybrid resin composite. The restorations were blindly assessed by 2 calibrated examiners using modified United States Public Health Service criteria at baseline and 1, 2, and 3 years. The data were analyzed using non-parametric tests (p = 0.05). Results: Eighty Class II restorations were evaluated. After 3-years, 4 restorations (5%) failed, 1 SDR + CeramX, and 3 CeramX restorations. The annual failure rate (AFR) of the restorations was 1.7%. The SDR + CeramX group revealed an AFR of 0.8%, and the CeramX group an AFR of 2.5% (p > 0.05). Regarding anatomical form and marginal adaptation, significant alterations were observed in the CeramX group after 3-years (p < 0.05). The changes in the color match were observed in each group over time (p < 0.05). Conclusions: The use of SDR demonstrated good clinical durability in deep Class II resin composite restorations.

Comparison of Nasal CPAP versus Bi-level CPAP in Transient Tachypnea of the Newborn: A Randomized Trial.

OBJECTIVE: The optimal noninvasive ventilation (NIV) modality in the treatment of transient tachypnea of the newborn (TTN) is still unknown. The aim of this study was to compare nasal continuous positive airway pressure (NCPAP) versus bi-level CPAP in the treatment of TTN. STUDY DESIGN: This was a prospective randomized study that was conducted in a tertiary level neonatal intensive care unit of Zekai Tahir Burak Women's Health Education and Research Hospital during the 1-year period between April 2017 and March 2018. The study included infants at ≥34 gestational weeks and birth weight ≥2,000 g who were diagnosed with TTN. The patients were randomized to either NCPAP or bi-level CPAP groups as initial respiratory support. The primary outcome was the rate of NIV failure. RESULTS: A total of 151 infants were incorporated into the study. The intubation rate was significantly higher in the NCPAP group (15/75) compared with the bi-level CPAP group (6/76) (p = 0.032). There was a significant decrease in the level of pCO2 at the 12 (60.7 ± 6.7 vs. 66.3 ± 8.8, p = 0.017) and 24 (50 ± 8 vs. 53 ± 10, p = 0.028) hours of NIV in the bi-level CPAP group compared with the NCPAP group. Duration of NIV, total respiratory support, hospital stay, and the incidence of pneumothorax were similar between the groups. CONCLUSION: Bi-level CPAP reduced the rate of NIV failure and pCO2 levels at the 12 and 24 hours in late preterm and term infants with a diagnosis of TTN. KEY POINTS: · Bi-level CPAP seems to be a safe and effective method in TTN.. · Bi-level CPAP may reduce the rate of NIV failure in late preterm and term infants with TTN.. · Future studies are warranted to answer the question whether bi-level CPAP might be used as a standard treatment in babies with TTN..